Drugs / Lactobacillus fermentum VRI 003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00294788 | Mar 2006 → Jan 2007 | influenza | Probiomics Ltd | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus fermentum VRI 003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00294788 ↗ |
| Known as | PCC | “specific strain of the probiotic bacterium Lactobacillus fermentum (trademarked PCC®)” NCT00294788 ↗ |
| Modality | Other / unclassified | “probiotic bacterium” NCT00294788 ↗ |
| Route | Oral | “oral consumption” NCT00294788 ↗ |